Here are three points:
1. The patent is titled “allografts combined with tissue derived stem cells for bone healing.”
2. The patent is related to AlloStem’s partially demineralized allograft bone combined with adipose derived mesenchymal stem cells.
3. AlloSource is one of the largest nonprofit cellular and tissue networks in the country.
More articles on devices:
Chondroitin sulfate proves effective for osteoarthritis patients — 5 findings
Alphatec’s shares dip by 4.39% — 4 points
Xtant Medical’s Aranax Cervical Plating System successfully used in 1st procedure: 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
